Circulating tumor DNA applications in monitoring the treatment of metastatic colorectal cancer patients

Colorectal cancer is the third most common cancer worldwide. New cancer treatment strategies such as monoclonal antibodies against growth factor and angiogenesis receptors have improved the overall survival (OS) and progression-free survival (PFS) in metastatic colorectal cancer (mCRC) patients. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazemifard, Nesa, Sadeghi, Amir, Varaminian, Behnaz, Rezvani, Hamid, Ayadi, Ahmad, Talaie, Ramin, Moshiri, Arfa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009314/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009314/

Ejemplares similares